Craig A. Tooman founded Stockbourne LLC. Presently, he is Chief Financial Officer for Silence Therapeutics Plc.
He is also on the board of CureVac AG and CureVac NV.
In his past career he was Chief Executive Officer for Avanzar Medical, Inc., Chief Operating & Financial Officer of Vyome Therapeutics, Inc., CFO, Executive VP & Head-Investor Relations at Enzon Pharmaceuticals, Inc., Principal at Stockbourne LLC, President & Chief Executive Officer for Aratana Therapeutics, Inc., Chief Financial Officer & Senior Vice President at Ikaria, Inc., Vice President-Investor Relations at Pharmacia & Upjohn, Inc., SVP-Strategic Planning & Corporate Communications at ILEX Oncology, Inc. and Vice President-Investor Relations for Pharmacia Corp.
Mr. Tooman received an MBA from The University of Chicago and an undergraduate degree from Kalamazoo College.